Determination of anti-idiotype antibodies by surface plasmon resonance

Journal of Immunological Methods

Volumn 214, Issue 1-2, 1998, Pages 113-119

  Haimovich, Joseph ^a   Czerwinski, Debra ^b   Wong, Carmen P ^b   Levy, Ronald ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cells; Monoclonal and polyclonal antibodies; Tumour immunotherapy

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; CANCER IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

EID: 0031867519     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00051-9     Document Type: Article

References (13)

1. Bergman Y., Haimovich J. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur. J. Immunol. 7:1977;317-413.
2. Campbell M.J., Carroll W., Kon S., Thielemans K., Rothbard J.B., Levy S., Levy R. Idiotype vaccination against murine B cell lymphoma: humoral and cellular responses elicited by tumour-derived IgM and its molecular subunits. J. Immunol. 139:1987;2825-2833.
3. Chen T., Tao M.H., Levy R. Idiotype-cytokine fusion proteins as cancer vaccines. J. Immunol. 153:1994;4775-4787.
4. Eshhar Z., Blatt C., Bergmann Y., Haimovich J. Induction of secretion of IgM from cells of the B cell line 38C-13 by somatic cell hybridization. J. Immunol. 122:1979;2430-2434.
5. Hsu F., Caspar C., Czerwinski D., Kwak L., Liles T., Syrengelas A., Taidi-Laskowski B., Levy R. Tumour-specific idiotype vaccines in the treatment of patients with B cell lymphoma - long term results of a clinical trial. Blood. 89:1997;3129-3135.
6. Johnsson B., Lofas S., Lindquist G. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198:1991;268-277.
7. Kaminski M.S., Kitamura K., Maloney D.G., Levy R. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumour immunity by free idiotype protein. J. Immunol. 138:1987;1289-1296.
8. Karlsson R., Fagerstam L., Nilshans H., Persson B. Analysis of active antibody concentration. Separation of affinity and concentration parameters. J. Immunol. Meth. 166:1993;75-84.
9. Kwak L.W., Campbell M.J., Czerwinski D.K., Hart S., Miller R.A., Levy R. Induction of immune responses in patients with B cell lymphoma against the surface immunoglobulin idiotype expressed by their tumours. N. Engl. J. Med. 327:1992;1209-1215.
10. Maloney D.G., Kaminski M.S., Burowski D., Haimovich J., Levy R. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C-13: characterization and use as probes for the biology of the tumour in vivo and in vitro. Hybridoma. 4:1985;191-209.
11. Okada C., Wong C., Denney D., Levy R. T cell antigen receptor vaccines for active immunotherapy of T cell malignancies. J. Immunol. 159:1997;5516-5527.
12. Slavin S., Strober S. Spontaneous murine B cell leukaemia. Nature. 272:1978;624-626.
13. Tao M.-H., Levy R. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B cell lymphoma. Nature. 362:1993;755-758.